GSK's blockbuster shingles vaccine submission accepted in Japan for wider use
- Shingles vaccine application submitted in Japan for 18+ adults- Extends use to younger population with compromised immune systems- Shingrix is one of GSK's fastest growing productsPharmaceutical giant GSK (GSK) said Japan's...
28 June 2022